What is the recommended evaluation and treatment approach for a pair of individuals with shared depression and shared psychosis, distinguishing the primary case from the secondary case?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Shared Psychotic Disorder (Folie à Deux): Evaluation and Treatment

Immediately separate the secondary case from the primary case, as physical separation alone often leads to spontaneous resolution of psychosis in the secondary individual, while the primary case requires standard antipsychotic treatment. 1, 2

Distinguishing Primary from Secondary Cases

The primary case (inducer) typically has:

  • Pre-existing psychiatric illness, most commonly schizophrenia 1
  • More severe and persistent psychotic symptoms 1
  • Psychotic symptoms that preceded the relationship or developed independently 2
  • Symptoms that persist despite separation 1

The secondary case (recipient) typically has:

  • Psychotic symptoms that developed only after prolonged exposure to the primary case 2
  • Delusions that mirror or closely match those of the primary case 1
  • Symptoms that often resolve within days to weeks after separation from the primary case 1
  • Premorbid vulnerability factors including dementia, depression, or intellectual disability 2

Critical Risk Factors to Assess

Evaluate for these predisposing conditions in both individuals:

  • Social isolation of the dyad (present in 67.3% of cases) 2
  • Close emotional bonds (90.2% occur in married couples, siblings, or parent-child relationships) 2
  • Comorbid conditions in the secondary case: dementia, depression, intellectual disability 2
  • Family psychiatric history and genetic burden 1
  • Duration and intensity of exposure to the primary case's delusions 2

Treatment Algorithm

Step 1: Immediate Separation

  • Physically separate the individuals as the first-line intervention 1
  • This alone may resolve psychosis in the secondary case within days 1
  • Monitor the secondary case closely during the first week post-separation 1

Step 2: Treatment of the Primary Case

Initiate antipsychotic treatment following standard psychosis protocols:

  • Offer antipsychotic treatment for psychotic symptoms lasting ≥1 week with distress or functional impairment 3
  • Choose the initial antipsychotic collaboratively based on side-effect and efficacy profiles 3
  • Trial at therapeutic dose for at least 4 weeks before considering inadequate response 3
  • If first antipsychotic fails after 4 weeks, switch to an agent with different pharmacodynamic profile 3
  • After two failed trials (each 4 weeks at therapeutic dose), consider clozapine with concurrent metformin 3

Step 3: Treatment of the Secondary Case

The modern approach includes pharmacotherapy, not just separation:

  • If psychosis persists beyond 1 week post-separation, initiate antipsychotic treatment 1
  • In the documented case, aripiprazole was effective for the more severely affected secondary case 1
  • Anxiolytics in low doses may be used adjunctively for acute distress 1
  • The prognosis is significantly better than for the primary case when specific treatment is provided 1

Step 4: Address Depression Component

For shared depression occurring alongside shared psychosis:

  • Treat underlying psychotic disorder first, as depression may be secondary 3
  • Assess for secondary causes of depressive symptoms: persistent positive symptoms, substance use, social isolation, medication side effects, medical illness 3
  • Consider antidepressant augmentation if depressive symptoms persist after psychosis improves 3

Common Pitfalls to Avoid

  • Do not delay separation while attempting pharmacological treatment alone—separation is therapeutic 1
  • Do not assume the secondary case will spontaneously recover without monitoring; modern evidence supports active pharmacological treatment if symptoms persist 1
  • Do not overlook comorbid conditions in the secondary case that increase vulnerability (dementia, depression, intellectual disability) 2
  • Do not miss hallucinations—they are common in shared psychotic disorder, not just delusions 2
  • Reassess diagnosis if symptoms fail to respond after two adequate antipsychotic trials, considering organic causes, substance use, or alternative diagnoses 3

Monitoring and Follow-up

  • Observe withdrawal of psychotic symptoms in the secondary case within the first week post-separation 1
  • Maintain separation until the secondary case demonstrates sustained symptom resolution 1
  • Continue treating the primary case with standard schizophrenia protocols, as their prognosis follows that of their underlying disorder 1
  • Address social isolation and strengthen social connections to prevent recurrence 2

References

Research

Shared psychotic disorder - a case study of folie à famille.

European review for medical and pharmacological sciences, 2022

Research

Shared psychotic disorder: a critical review of the literature.

Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1995

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.